Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels

BACKGROUND: Chronic kidney disease (CKD) is a risk factor for end-stage renal failure and cardiovascular disease, and a strategy to counteract CKD must be established. CKD caused by immunological abnormalities is treated by steroids, frequently resulting in steroid diabetes. Although insulin is the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ohashi, Naro, Tsuji, Naoko, Naito, Yoshitaka, Iwakura, Takamasa, Isobe, Shinsuke, Ono, Masafumi, Fujikura, Tomoyuki, Tsuji, Takayuki, Sakao, Yukitoshi, Yasuda, Hideo, Kato, Akihiko, Fujigaki, Yoshihide
Formato: Artigo
Idioma:Inglês
Publicado em: International Scientific Literature, Inc. 2014
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989946/
https://ncbi.nlm.nih.gov/pubmed/24717767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.889872
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados